Podcasts about hormonal therapy

Menopausal hormonal therapy should not be a blanket recommendation for everyone going through menopauseWeight management in women is influenced by hormonal changes throughout life stages.Retrospective analyses can provide insights but have limitations.The wellness industry often oversimplifies complex medical issues.Hormonal replacement therapy may have subtle benefits for weight management.Confounding factors like SSRIs can complicate weight loss efforts.A holistic approach is essential for managing women's health during menopause.Education and awareness are crucial for women navigating menopause.Future research should focus on randomized controlled trials for better clarity.Understanding individual patient experiences is key to effective treatment.Click here to see her studyClick here to follow Dr. Tchang on XClick here to join Dr. Spencer's clinic Vineyard 

At the 2025 American Society of Clinical Oncology Annual Meeting, Hope Rugo, MD, chaired a session on managing the side effects of new breast cancer treatments and also presented information on how to manage the side effects of hormonal therapy medicines, which are used to treat hormone receptor-positive breast cancer. Listen to the episode to hear Dr. Rugo explain: ways to manage the side effects of tamoxifen and the aromatase inhibitors why talking to your doctor about side is crucial to managing them her advice for people who are having side effects from hormonal therapy medicines

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer (PC) — Professor Karim Fizazi, MD, PhD CME information and select publications

Featuring perspectives from Dr Rahul Aggarwal and Dr William K Oh, including the following topics: Hormonal Therapy for Patients with Prostate Cancer — Dr Oh (0:00) Other Available and Emerging Therapeutic Approaches — Dr Aggarwal (27:14) CME information and select publications

Dr. Amy Novatt delves into the complex and often misunderstood realm of menopause hormonal therapy, previously known as Hormone Replacement Therapy (HRT). Dr. Novatt is joined by Dr. Liz Lyster, an OB-GYN and midlife health expert, to discuss the history, controversies, and current understanding surrounding hormone therapy. The conversation includes an in-depth look at the impact of the landmark 2002 Women's Health Initiative (WHI) study, which drastically changed the public perception and medical approach to HRT, and moves on to explore bio-identical hormones, safer methods of administration, and the importance of individualized treatment plans. Dr. Lyster provides expert insights into the benefits of hormone therapy, including its role in alleviating menopausal symptoms, improving bone density, and potentially lowering the risks of heart disease, dementia, and certain cancers. Both hosts emphasize the significance of personalized medical advice and the need to consider each woman's unique health profile and family history. The episode also covers practical advice on when to start hormone therapy, the importance of a baseline bone density scan at age 50, and the often misunderstood concept of 'estrogen dominance.' They encourage listeners to proactively engage with their healthcare providers and to consider hormone therapy as a viable option for improving quality of life during the menopausal transition. On a more personal note, Dr. Lyster shares her recent experiences with loss and grief. This segment underscores the broader theme of reinvention and resilience during midlife, touching on how managing one's health can help navigate the emotional and physical changes that accompany this stage of life. Questions of comments? Call 845-307-7446 or email comments@radiofreerhinecliff.org Produced by Jennifer Hammoud and Matty Rosenberg @ Radio Free Rhiniecliff

Editor’s Choice: The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study Editorial: Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit – That's a relief!

New research suggests that estrogen plays a role in allowing hormone receptor-negative breast cancer to grow. This is because estrogen limits the ability of the immune system to attack cancer cells; it also makes immunotherapy medicines, like Keytruda (chemical name: pembrolizumab), less effective. Dr. Donald McDonnell, senior author of the study, explains the results and how they might make a difference for people with breast cancer. Listen to the episode to hear Dr. McDonnell explain: what eosinophils are and how he started studying them in connection with breast cancer how estrogen in the body affects the immune system how a hormonal therapy medicine, like tamoxifen, can make an immunotherapy medicine, like Keytruda, more effective

Apply to the Cancer Freedom Program here: www.cancerfreedomprogram.com   Of course you know that taking hormonal therapy will help prevent your cancer from coming back.  But you also know the side effects are SCARY!     Life changing.  You don't feel like yourself.  Now - you want to quit.  What should you do?   In this episode I'm showing you exactly what you need to know if you want to quit taking hormonal therapy for breast cancer.  Whatever you decide, you have my support.  Let's get you all the right information first!   So let me show you how it's done.   Join the Cancer Freedom Program Click HERE www.cancerfreedomprogram.com   #cancersurvivor #cancerfighter #breastcancer #cancerrecovery #cancernutrition #mastectomy #tamoxifen #anastrozole #letrozole #signatara   PS - Whenever you are ready, here the 2 best ways I can help you -    1) “Your A-Z Guide to Staying Cancer Free” **FREE** Click here: https://bit.ly/azcancerfree   2)Join the Cancer Freedom Program  Click HERE: www.cancerfreedomprogram.com   ***Let's Connect: Website: www.cancerfreedomprogram.com Instagram: https://www.instagram.com/dramymorris/ YouTube: https://www.youtube.com/channel/UCUt9... Facebook: https://www.facebook.com/dramycancer/

In the THRIVE trial, sexual side effects caused by hormonal therapy led to lower mental quality of life in both Black and white women, but caused lower physical quality of life only in Black women. Sexual side effects were also linked to Black women being less likely to take hormonal therapy as prescribed, but not white women. Dr. Janeane Anderson, who analyzed the THRIVE data, explains why it's so important for anyone who's received breast cancer treatment to talk to their doctors about any and all sexual health problems they're having. Listen to the episode to hear Dr. Anderson discuss:  Why sexual health is one of the most significant unmet needs among breast cancer survivors of breast cancer, regardless of race. The most common sexual health side effects of hormonal therapy. Her advice to women who aren't comfortable talking about sex and sexuality with their oncologists.

Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O'Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics: Introduction (0:00) Role of Hormonal Therapy in Prostate Cancer Management — Dr M Smith (10:54) Other Available and Emerging Therapeutic Approaches — Dr Srinivas (37:03) CME information and select publications

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published updated meta-analysis on impact of gender-affirming hormonal therapy on cardiovascular risk factors in transgender health.

In a episode of *Your Health Matters*, host Karl Sterling, co-host Elizabeth Bruce, and guest expert Dr. Sherie Viencek explored the connection between hormones and brain health, especially in relation to aging and cognitive conditions like Alzheimer's disease. Dr. Viencek, with over 30 years of experience in integrative health, shared insights into how hormonal changes impact brain function and overall well-being. Hormonal Therapy and Brain Health Dr. Viencek explained the optimal timing for starting hormone replacement therapy (HRT), emphasizing that starting at 55 or older significantly reduces biological aging. Research from Stanford shows that continued HRT use enhances metabolic activity and brain function. She pointed out that the old recommendation to stop HRT at 60-65 is now considered outdated. Recent guidelines suggest discontinuing HRT based on personal health needs rather than age. Key points: - HRT at 55 or older: Reduces biological aging and supports brain function. - Ongoing HRT: Benefits metabolism and cognition. - New guidelines: Routine discontinuation at 60-65 is no longer necessary. Thyroid Health Dr. Viencek noted that around 20 million Americans have hypothyroidism, with many undiagnosed due to inadequate thyroid testing. She stressed the importance of comprehensive thyroid panels, including antibody testing, as low T3 hormone levels are linked to depression and cognitive issues. This highlights the importance of thorough thyroid evaluations, especially for patients with depression. Key points: - Hypothyroidism prevalence: 20 million Americans, with many undiagnosed. - T3 hormone: Critical for brain function, low levels linked to depression. - Comprehensive thyroid panels: Necessary for accurate diagnosis. Lifestyle Factors for Brain Health Dr. Viencek shared findings from the UK Biobank that regular napping is associated with larger brain volume, suggesting potential protection against cognitive decline. Additionally, she discussed a study showing that inhaling pleasant aromas during sleep can significantly improve memory, revealing the impact of sensory experiences on cognitive health. Key points: - Napping: Linked to larger brain volumes and potential cognitive protection. - Pleasant aromas during sleep: Can enhance memory. Meditation and Cognitive Function Dr. Viencek recommended a daily 12-minute meditation practice called *Chi Pre Yoga*, which has been shown to reduce the risk of Alzheimer's, improve memory, sleep quality, and boost immune function. Meditation, she emphasized, is a simple yet powerful tool for brain health. Key points: - Chi Pre Yoga: A daily 12-minute meditation that helps reduce Alzheimer's risk. - Benefits: Improves memory, sleep, and immunity. Conclusion and Call to Action Karl Sterling encouraged listeners to take proactive steps in their health, particularly by seeking comprehensive hormonal and thyroid evaluations. Dr. Viencek emphasized the importance of understanding how hormonal balance impacts brain health and urged listeners to address these issues early for better cognitive function as they age. Listeners were reminded to consult healthcare providers for personalized advice and to stay informed through Dr. Viencek's resources at Sage Functional Health, which includes upcoming webinars on hormone testing and management. This episode offered valuable insights into how hormones, lifestyle choices, and practices like meditation can significantly influence brain health, providing actionable steps to maintain cognitive function and well-being as we age. Be sure to visit http://www/sagefunctionalhealth.com

In this episode of Stellar Cycles, we're diving into endometriosis—a common but often overlooked condition affecting women's reproductive health. As someone with hands-on experience in women's health, I'll explain what endometriosis is, the symptoms you should be aware of, how it's diagnosed, and its potential causes. We'll explore key topics like endometriosis symptoms, diagnostic tests, and treatment options, including hormonal therapy and surgical interventions. I'll also share tips on managing chronic pain, understanding the condition's impact on fertility, and improving your overall quality of life. Whether you're newly diagnosed or looking for more information, this episode aims to simplify the complexities of endometriosis management and help you feel more informed. Remember, this is just an overview based on my experience—always consult your doctor for personalized advice. Tune in to get the facts on endometriosis, its challenges, and how to manage it in your daily life. Don't forget to like, comment, and subscribe for more tips on women's health, wellness, and reproductive health!Download our FREE phasic foods grocery guide here! Stellar Cycles Instagram @stellarcyclespod Use code STELLAR10 for 10% off BioOptimizers magnesium supplementsListen on SpotifyListen on Apple Podcasts

In this episode, Yvonne Gilleece, MB BCh, BAO, FRCP, uses a case study to illustrate why giving people space and time to engage in HIV care on their terms is key to overcoming potential shame and stigma.She discusses how people can be very vulnerable when engaging in HIV care, and trauma-informed care can help address these vulnerabilities in a safe, respectful way. Listen as she gives her perspectives on:Trauma-informed careOvercoming stigma and shameStaying in care Presenter:Yvonne Gilleece, MB BCh, BAO, FRCPHonorary Clinical Professor and Consultant in HIV Medicine & Sexual HealthBrighton & Sussex Medical School and University Hospitals Sussex NHS Foundation TrustChair of the British HIV AssociationLead for HIV & WomenLead for HIV & HepatitisBrighton, United KingdomContent based on an online CME program supported by an educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xicSeFGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Ever wondered if hormones could be the secret culprit behind relationship ups and downs? In this revealing episode of The Dr. Terri Show, my husband Dan DeNeui and I dive deep into the surprising ways hormones can affect everything from intimacy and communication to mood swings and stress levels. We share our own personal experiences, insights, and advice on how to navigate hormonal changes, improve communication, and strengthen your relationship. --- The Dr. Terri Show is presented by Evexias Health Solutions, for more visit: https://www.evexias.com/

Hormone Replacement Therapy has existed long in the 60's before we were even taught of the right dosages for women. In fact, up until the 90's, medical studies mostly excluded women, making medical solutions only in consideration of men. With this in mind, have you ever asked yourself if you've been giving your body the right care especially once you're undergoing perimenopause and menopause?Join us in this episode as Dr. Stephanie Nielsen, one of our in-house clinicians, dive into different research studies with Dr. Betty Murray, Founder of Living Well Dallas, a Functional Medicine Center that provides whole body patient-centric care. Dr. Stephanie and Dr. Betty discuss the context behind hormonal therapies - which you may not even be aware that you have already been taking to manage your body such as birth control pills despite not knowing of potential risks and benefits of each one towards your symptoms.Dr. Stephanie and Dr. Betty also debunk myths, and go into the differences and impact of hormonal replacement therapy and bioidentical hormone replacement therapy. Hormone replacement therapy being synthetic, while bioidentical hormone replacement therapy being more similar to what already exists and what is being produced by the body. Though they may be used for the same purpose, but definitely have different implications on the body. Don't miss out on today's episode to ensure you make the best decisions for your body! Here are some of the concepts that were discussed throughout the episode as well:The Impact of Birth Control PillsDiscussing the Initial Study of the Women's Health InitiativeConsidering Health Stages, Risks, and HabitsThe Differences and Similarities of HRT and BHRTHow Hormones Work and Get ProducedMedications that may screw up your liverProper Ways of Looking Into Research Studies on HealthImportance of Looking Into Your DNADementia and HormonesDiet and Menopause▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Keep yourself up to date on The DNA Talks Podcast! Follow our socials below:The DNA Talks Podcast Instagram https://www.instagram.com/dnatalkspodcast/Dr. Stephanie Nielsen's website https://www.wishinguwellness.com/Dr. Betty Murray's website at https://www.bettymurray.com/You may also watch this episode on YouTube.▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Music: Inspiring Motivational Background by Stock-Waveshttps://www.stock-waves.com/https://protunes.net/Video Link:  https://www.youtube.com/watch?v=pbwVDTn-I0o&list=PLQtpqy3zeTGB7V5lkhkfBVaiZyrysv_fG&index=5▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Music: Peaceful Corporate by Stock-Waveshttps://protunes.net/Video Link:  https://www.youtube.com/watch?v=I34bTKW8ud0&list=PLQtpqy3zeTGB7V5lkhkfBVaiZyrysv_fG▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬Medical Disclaimer: The intention of this podcast is to enhance your lifestyle by changing what is within your control. This does not substitute the medical advice given by your personal doctor, therapist, and other healthcare professionals.

Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics: Introduction (0:00) The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21) The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18) Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27) Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40) NCPD information and select publications

Featuring perspectives from Dr Rahul Aggarwal, Dr Adam S Kibel, Dr Laurence Klotz and Dr Sandy Srinivas, moderated by Dr Elisabeth I Heath, including the following topics: Introduction (0:00) Recent Data Defining the Optimal Use of Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Kibel (2:39) Side Effects and Other Practical Considerations with Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Klotz (27:04) Current and Future Approaches to Hormonal Therapy for Metastatic Prostate Cancer — Dr Aggarwal (51:07) New Considerations with the Use of PARP Inhibitors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Dr Srinivas (1:13:53) Other Novel Therapies for Patients with Metastatic Prostate Cancer — Dr Heath (1:38:52) CME information and select publications

Featuring perspectives from Dr Andrew J Armstrong and Ms Brenda Martone, including the following topics: Introduction: Overview of Prostate Cancer; Hormonal Therapy (0:00) Radiopharmaceuticals for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) (24:11) Biomarker Testing for mCRPC; PARP Inhibitors for mCRPC (49:33) NCPD information and select publications

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Rana R McKay, including the following topics. Role of Hormonal Therapy in Prostate Cancer (PC) Management — Dr McKay (0:00) Evidence-Based Use of Other Therapeutic Approaches — Dr Antonarakis (35:15) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy and Novel Therapeutic Strategies for Patients with Prostate Cancer — Maha Hussain, MD, FACP, FASCO CME information and select publications

Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain, including the following topics:  Introduction: Carpool Karaoke — RTP Style (0:00) Hormonal Therapy (13:36) Other Treatment Approaches (36:50) CME information and select publications   

Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Prostate).

HOST - Dawn Marie R. Davis, M.D. GUEST - Jewel M. Kling, M.D., M.P.H. The number of midlife women transitioning into menopause is substantial with more than one million women in the U.S. entering menopause each year. Symptoms such as vasomotor symptoms (VMS), mood and sleep disturbances, and sexual problems are common during the menopause transition, yet often go untreated. Menopausal hormone therapy (HT) is often the preferred and most effective treatment option for menopausal symptoms. Dr. Juliana (Jewel) Kling joins the podcast to discuss this important topic. This episode is brought to you by: https://www.astellas.com/us/  Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.  Learn more about this episode at: https://ce.mayo.edu/online-education/content/mayo-clinic-talks-menopause-and-womens-health-edition

Host: Zachery Reichert MD, PhD If hormonal therapies are not working for prostate cancer patients, chemotherapy may be a reliable alternative based on findings from a recent study. In fact, out of the 70 percent of patients who had pain when entering the study, 45 percent had their pain improved with chemotherapy. Dive more into the findings with Dr. Zachery Reichert, who presented the “Sequencing Hormonal Therapies After Treatment Intensification” session at the 2024 ASCO Genitourinary Cancers Symposium.

Host: Zachery Reichert MD, PhD If hormonal therapies are not working for prostate cancer patients, chemotherapy may be a reliable alternative based on findings from a recent study. In fact, out of the 70 percent of patients who had pain when entering the study, 45 percent had their pain improved with chemotherapy. Dive more into the findings with Dr. Zachery Reichert, who presented the “Sequencing Hormonal Therapies After Treatment Intensification” session at the 2024 ASCO Genitourinary Cancers Symposium.

In this episode, Dr. Rena Malik discusses the complex topic of low sexual desire. She delves into the prevalence of low libido in both men and women, highlighting the various factors that can impact sexual desire, including medications, relationship issues, stress, and psychological disorders. Dr. Malik shares insights on the role of the brain in sexual desire, as well as the potential impact of mindfulness practice, nutrition, sleep, and exercise on improving sexual function. She also explores the use of supplements, medications, and hormone replacement therapy as potential interventions. Join us as we explore the multifaceted nature of sexual desire and the potential strategies for addressing low libido. Become a Member to Receive Exclusive Content: renamalik.supercast.com Schedule an appointment with me: https://www.renamalikmd.com/appointments ▶️Chapters: 00:00 - Introduction 02:23 - Understanding the Prevalence of Low Sexual Desire and Its Impact 08:49 - The Role of the Brain in Sexual Desire: Neurological Signal Pathways 13:20 - Medications and Their Influence on Sexual Desire 18:45 - Relationship Issues, Stress, and Psychological Factors in Low Sexual Desire 24:10 - The Impact of Mindfulness Practice on Body Image and Sexual Satisfaction 29:57 - Nutritional and Lifestyle Factors Affecting Sexual Desire 34:18 - Scheduling Intimacy and its Role in Awakening Desire 39:02 - Communicating with Your Partner for a Fulfilling Sex Life 43:50 - Medical Solutions for Low Libido: Medications, Hormonal Therapy, and Supplements 48:15 - Conclusion Let's Connect!: WEBSITE: http://www.renamalikmd.com YOUTUBE: https://www.youtube.com/@RenaMalikMD INSTAGRAM: http://www.instagram.com/RenaMalikMD TWITTER: http://twitter.com/RenaMalikMD FACEBOOK: https://www.facebook.com/RenaMalikMD/ LINKEDIN: https://www.linkedin.com/in/renadmalik PINTEREST: https://www.pinterest.com/renamalikmd/ TIKTOK: https://www.tiktok.com/RenaMalikMD ------------------------------------------------------ DISCLAIMER: This podcast is purely educational and does not constitute medical advice. The content of this podcast is my personal opinion, and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of information contained in this podcast including but not limited to economic loss, injury, illness or death. Learn more about your ad choices. Visit megaphone.fm/adchoices

Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer, including the following topics: Introduction: Endocrinology and Pharmacology of Hormonal Therapy for Breast Cancer (0:00) Current and Emerging Strategies for Localized Hormone Receptor (HR)-Positive Breast Cancer — Dr Graff (17:02) Advances in the Care of Patients with HR-Positive Metastatic Breast Cancer — Dr Mayer (38:59) CME information and select publications

 In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Brian Slomovitz to discuss hormonal therapy in advanced or recurrent endometrial cancer. Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies. Highlights: While current recommendations include chemotherapy as first-line treatment for metastatic or recurrent endometrial cancer, emerging evidence suggests that hormonal therapy, particularly in combination with other treatment regimens guided by biomarkers, could be efficacious in selected subtypes (low-grade endometrioid carcinoma of the endometrium). Hormonal therapy offers many benefits, including oral dosing and fewer side effects. If there is progression after hormonal therapy, patients would still be eligible for other trials, and use of hormonal therapy does not preclude the use or limit the benefits of future chemotherapy.    

Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Harold Burstein, Dr Asher Chanan-Khan, Dr Komal Jhaveri, Dr Brad S Kahl, Dr Alicia K Morgans, Dr Philip A Philip, Dr Gregory J Riely, Dr Matthew R Smith and Dr Heather Wakelee, including the following topics: Introduction (0:00) Role of Hormonal Therapy in Prostate Cancer Management — Dr Smith (1:50) Clinical Questions and Cases (13:18) Evidence-Based Use of Other Therapeutic Approaches in Metastatic Castration-Resistant Prostate Cancer — Dr Morgans (26:08) Clinical Questions and Cases (38:01) CME information and select publications

Disclaimer:The views and opinions expressed during this podcast are those of the physicians participating and do not necessarily reflect the position of the SOGC.   In this enlightening episode, we delve into the often-misunderstood topic of menopause.   Join Heather Olszewski as she sits down with menopause expert, Dr. Michelle Jacobson, to explore the physical, emotional, and psychological aspects of this natural life transition that every woman goes through.   Dr. Jacobson, with her extensive background in women's health, offers a deep understanding of the complexities of menopause. Together, we tackle the questions and concerns that many women face during this transformative stage of life.   Throughout our discussion, Dr. Jacobson shares her insights on the physiological changes that occur during menopause, including hormonal fluctuations and their effects on the body.   But menopause isn't just about the physical changes; it's a multifaceted experience. Our conversation delves into the emotional and psychological aspects, addressing issues like self-esteem, relationships, and coping strategies. We explore how menopause affects different women in unique ways, emphasizing the importance of personalized care and support.   Join us as we demystify menopause, challenge misconceptions, and offer guidance for women, their partners, and healthcare providers alike. By the end of this episode, you'll have a comprehensive understanding of this natural phase of life, and the knowledge you need to embrace it with grace and confidence.   Tune in for this insightful conversation and gain valuable insights into navigating the journey of menopause with resilience and empowerment.   Links discussed in the episode:  SOGC Ontario CME The Canadian Menopause Foundation

In this episode I have the privilege of speaking to Eva Bueno, mostly known as Eva Loves Raw! Eva was fully raw for over 6 years to turn her health around and prevent a suggested hysterectomy and since then her life changed; giving birth to her You Tube Channel, her coaching programs and the life she always wanted to live!  We speak about her journey, transformation and development within her raw Vegan diet. This episode is brought to you by Dr Morse's Healing herbs, which I am an affiliate of , please feel free to order from my link to support my Podcast https://drmorsesherbalhealthclub.com/liveleanhealth use code GREENLIFE for 5% off A special thanks to Namawell, the best cold press juicers on the planet with the revolutionary J2. To get your Nama juicer at a discount, use code CHANTAL10 for 10% off! https://www.namawell.comCheck out our Farm in Northern Portugal for events and stays https://www.liveleanhealth.com/events and please also check my services if you wish to work with me.  About Eva Eva was born in Spain in the 70s and moved to the United States to study abroad at the age of  17. She immediately fell in love with everything the US had to offer, and one of the first things she came to love most was American food! Growing up in Spain  meant sticking to a traditional diet of meat and dairy with some fruits and vegetables. She almost never ate junk food, fast or processed food. But, In spite of not having had junk foods growing up, Eva's diet was not great as it did include lots of pastries, oils, fried foods and traditional Spanish foods which were heavy in fats. Between her diet growing up, and the newly found diet in the US, Eva found herself plagued by hormonal and other health issues around the time she hit her early forties. She had started eating more fruits and vegetables,  had been vegetarian and, unfortunately, a junk food vegan for some years, but the damage had been done.  During this challenging time, Eva's period would start and then last 2-3 weeks of extremely heavy flow.  Twice she was so weak from blood loss, she was told she needed a blood transfusion. Eva's gynecologist put it all down to age and declared what she called peri- menopausal issues as “normal”. She went on to prescribe Hormonal Therapy, recommended a painful procedure to have the lining of her uterus scraped off followed by a hysterectomy, if that treatment didn't yield the desired result. Eva declined, feeling deep inside that there had to be a better way to heal, and that pills and surgery were just a quick fix that didn't address the real cause of her troubles. Eva took stock of all the symptoms she was suffering with : extreme mood swings, bad breath, hair loss, body odor, acne, weakness and fatigue, on and off depression, anxiety, eye bags, extreme food addictions and an overall sense of just not feeling good no matter how long she slept or rested, and decided to take matters in her own hands Eva found the Raw Food lifestyle after attending the Hippocrates Health Institute! What a transforming miracle raw foods brought on! Eva has been a raw foodie consistently since 2014 and it has changed her whole outlook on life.To reach Eva and work with her directly please visit: https://www.eva-loves.com/To join Eva's Private Community: https://www.eva-loves.com/thrive-and-...If you're stuck for raw vegan recipes visit. https://www.eva-loves.com/ and get a free recipe ebook when you sign up to be in Eva's mail-list Follow Eva on Social Instagram https://www.instagram.com/evalovesraw/ You Tube https://www.youtube.com/channel  

This Podcast features Dr Jakkrapatara Boonruang (Dr Fair), who is a research physician at Thailand's Institute of HIV Research and Innovation (IHRI). He shares insights about gender affirming hormonal therapy for transgender people, barriers to its access, and recommendations on how to scale it up with inclusion, rights, ethics, people-centric approaches, and science.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.ThanksCNS team

Hormonal therapy can cause a number of troubling issues for women, including loss of libido, hot flashes, and pain during sex. At the 2023 American Society of Clinical Oncology Annual Meeting, Dr. Kristin Rojas chaired a session called “A Juggling Act: Managing the Toxicity of Estrogen Deprivation for Patients With Breast Cancer.” Listen to the podcast to hear Dr. Rojas explain: some of the most problematic issues and how they can be treated some of the therapies, products, and devices to avoid how women can find help for sexual issues

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer — Faculty Presentation 1: Optimizing the Use of Hormonal Therapy in Prostate Cancer Management — Tanya B Dorff, MD CME information and select publications

Turns out we have a lot of listeners who know things about rye grass, and another who had a spontaneous one-week romantic liason that started with an empty stomach.

Our next guest is one such multi-faceted person who knows the world of medicine, and tracks the FemTech ecosystem too. Join us, as we head into a conversation with Dr. Shabnam Das Kar, as she gives us an overview of Hormonal Therapy, and also gives the blueprint to the different types of Hormonal Therapy. She also helps us understand how Hormonal Therapy is evolving into menopause, alongside other forms of treatment. On the FemTech front, she sheds light on how Hormonal Therapy is gaining acceptance as a form of treatment, and why there is an inherent lack of awareness among patients. She also draws a map on the ideal window to commence Hormonal Therapy, and mentions specific life-stage such as menopause versus the onset of menopause, and the correlation to commence Hormonal Therapy. Professionally, Dr Shabnam Kar is a Certified MD (OBGY), FMNM, Specialist in Functional Medicine, Brain Health Coach Director of Medical Education at Better Medical Centre, Calgary- Canada. Alongside, she is also one of the Advisors on Board, at FemTech India. Join us, as she gives us a highly information overview on Hormonal Therapy. DISCLAIMER: The content in the podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider.  Connect with FemTech India Website: https://www.femtechindia.com/Linkedin: https://www.linkedin.com/company/femtechindiaorg/Twitter : https://twitter.com/Femtech_india?t=HIyteldoOxSIAXwsEXYv4w&s=09Instagram: https://www.instagram.com/femtechindia_podcast?igsh=bzd4a2ZheXc0cm1sYoutube : https://www.youtube.com/@TheFemTechIndiaPodcast Connect with Navneet Linkedin : https://www.linkedin.com/in/navneet-kaur-80109b227/Twitter : https://twitter.com/Navneet_Kaurrrr

Doctors are looking for new treatment options for people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer that has grown during treatment with hormonal therapy and a CDK4/6 inhibitor. Dr. Virginia Kaklamani is part of the team investigating elacestrant, an oral medicine, to see if offers more benefits than Faslodex (chemical name: fulvestrant), which is the current standard of care. Listen to the podcast to hear Dr. Kaklamani explain: the type of medicine elacestrant is and how it works why it's important that elacestrant showed benefits for breast cancers with an ESR1 mutation when we might hear if elacestrant is approved by the U.S. Food and Drug Administration (FDA)

Featuring perspectives from Prof Karim Fizazi and Prof Stéphane Oudard, including the following topics: Introduction: Journal Club — Karim Fizazi, MD, PhD and Stéphane Oudard, MD, PhD (0:00) Case: A man in his late 50s with Gleason 7 prostate cancer after prostatectomy/radiation therapy/androgen deprivation therapy (ADT) experiences biochemical recurrence 2 years later (PSA 0.5; doubling time 9 months) — Philip L Brooks, MD (10:58) Case: A man in his early 70s with a pacemaker presents with de novo metastatic hormone-sensitive prostate cancer (mHSPC) after cerebrovascular accident — Nasfat Shehadeh, MD (28:50) Case: A man in his late 40s with multiple medical comorbidities presents with de novo mHSPC (PSA 19.4) and responds to ADT/docetaxel — Gurveen Kaur, MD (47:00) Case: A man in his mid 60s with de novo mHSPC receives leuprolide, and PSA levels decrease from 865 ng/mL to 1.34 ng/mL — Joanna Metzner-Sadurski, MD (50:38) Case: A man in his late 50s with mHSPC receives leuprolide, experiences disease progression 1.5 years later and responds to abiraterone/prednisone but on liquid biopsy is found to have an AR T878 mutation — Niyati A Nathwani, MD (54:30) Case: A man in his mid 60s presents with de novo metastatic prostate cancer and experiences disease progression on ADT + docetaxel, now with progressive disease on abiraterone/prednisone; germline CHEK2 mutation — Syed F Zafar, MD (56:51) CME information and select publications  

Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.

Going through chemo and cancer treatment, you probably thought you were done with cancer once you run the bell.  Wrong. Bring on Tamoxifen therapy for 5 years, 10 years, or even indefinitely can mean you feel like a stranger in your body.   But here is the good news - there are steps you can take to get rid of these side effects.  For those on tamoxifen, you will want to listen to this episode because we are diving into the side effects of the drug and what you can do to be free from those side effects. 

Featuring perspectives from Dr Matthew Smith, including the following topics: Introduction: Abemaciclib for Prostate Cancer? (0:00) Case: A man in his early 70s with a PSA of 150 ng/mL, Gleason 4 + 4 and upper abdominal adenopathy — Jennifer L Dallas, MD (9:30) Case: A man in his late 60s with Gleason 4 + 4, PSA of 147 ng/mL and a negative CT — David S Morris, MD (34:30) Case: A man in his late 60s with coronary artery disease and Gleason 4 + 4 who underwent external beam radiation therapy (EBRT) in 2013 and now has increasing PSA of 3.8 with a 6-month doubling time — Gurveen Kaur, MD (37:56) Case: A man in his mid 60s who experiences M0 progression after EBRT followed by androgen deprivation therapy (ADT) but refuses to continue ADT — Henna Malik, MD (41:44) Case: A man in his early 50s with a slowly rising PSA (now 1.31) after radical prostatectomy and salvage radiation therapy; PSMA PET scan denied by insurance, now appealed — Kapisthalam (KS) Kumar, MD (50:23) Case: A man in his late 70s with Gleason 5 + 4 and a PSA of 23 ng/mL increasing after EBRT followed by ADT, cryoablation and enzalutamide; after a response, 18F-fluciclovine PET shows subtle focus of uptake in left prostate — Susmitha Apuri, MD (57:06) CME information and select publications

Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.

Week 35 The Drs Guide. Health Optimization Strategies 2022 : Why you don't want hormonal therapy for men & women

Join us as we take a deep dive into Lizzy's personal experience with pellet bioidentical hormone therapy.  Remember that we are not doctors, consult an actual one and check out biote.com to see how you can look and feel younger and extend your vitality and frankly - be more like Lizzy.  We take a few detours into chin hairs, effortless threesomes, hair boners, and lots of myths about hormone therapy.Support the show

CME credits: 1.00 Valid until: 24-06-2023 Claim your CME credit at https://reachmd.com/programs/cme/novel-hormonal-therapy-advances-in-metastatic-hormone-sensitive-prostate-cancer/14023/ tbd

Deon Hall-Garriques is a Certified Public Accountant (CPA), Holistic Health Coach from the Institute of Integrated Nutrition and co-author of the best-selling book, “Building Beyond the 9 to 5”. She is the founder & CEO of Deon's Wellness Wagon, where she coaches and educates women on health and nutrition. She is an expert in women's health, and creator of the Five-Step Hormone Rebalance Program. Deon has been featured in VoyageLA magazine and has been dubbed the“Healthspirationist” and “Menopause mama” because of her success in helping perimenopausal and menopausal women transition naturally. Deon is also a workshop facilitator and has spoken at Fortune 500 corporations, wellness conferences, summits, retreats, community organizations, women's groups, and several podcasts. Her signature talks, “Banking For Your Health” and “3 Secrets & The Keys To Naturally Losing Belly Fat And Keeping It off” have gotten rave reviews. Episode Notes: A good marriage is based on Communication, Respect & Trust. When you layer everything in, friendship is the foundation of a strong relationship. Understanding the different phases women transition through life. Perimenopausal, Menopause, and Post Menopause. The importance of hormonal balance during the menopausal years. What it means to be Estrogen dominant. Not all women require Hormonal Therapy. Lifestyle changes can help to reduce, alleviate, and minimize a lot of the symptoms of hormonal imbalances. Three key components assist in a smooth hormonal transition as women age beyond 35 years. Your Diet should be your foundation. / Supplements due to soil quality. Movement - whatever it looks like for you. Our entire body needs us to move. Get up and move! Mindful of your thoughts/ Mindset / Relationships Spring is time to reset and cleanse your bodies. Five-Step Hormone Rebalance Program SEEDS Supplementation Exercise Essential Oils Diet Self-Care Armor your children with tools for life. Give them a voice so they feel included in making decisions that impact them. The importance of celebrating our cultural heritage as diasporas from our homeland. Register to attend the Spring 10 Day Hormorne Rebalance Detox Program: https://www.deonhall.com/spring-jumpstart Purchase Deon's most recent Book: Building Beyong the 9 to 5 Connect with Deon: Facebook: https://www.facebook.com/deon.hall.967 Website: https://www.deonhall.com Instagram: https://www.instagram.com/deonswellnesswagon/ _________________________________________________________ Connect with Farrah La Ronde-Hutchison @gaiatarian Website: https://bit.ly/2ZE6dKo Instagram: https://bit.ly/3CwE6eM YouTube:https:https://bit.ly/30dZNlA Podcast: https://anchor.fm/beastmamas

CME Available: https://auau.auanet.org/node/35401 Learning Objectives: After participating in this educational series, participants will be able to: 1. List advanced prostate cancer disease states (mHSPC); M0 CRPC and M1 CRPC) and be able to identify these patients in urologic practice. 2. Identify available approved therapies and outcomes for each of these disease states: MHSPC, M0 CRPC, M1 CRPC. 3. Demonstrate the appropriate indications, unique mechanisms of action and side effects of new and existing androgen axis agents, immunotherapies, chemotherapeutic agents and bone targeted therapies. 4. Explain the sequencing of available therapies, as well as identifying adverse events that might occur when considering combination therapy. 5. Review the evidence and outcomes on androgen deprivation treatment alone and in combination as outlined in the newly released Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline. Acknowledgements: Support provided by independent educational grants from: AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck

Featuring perspectives from Drs Neeraj Agarwal, Himisha Beltran, Fred Saad and A Oliver Sartor, moderated by Dr Alan Bryce, including the following topics: Introduction (0:00) Optimal Use of Hormonal Therapy in Nonmetastatic Prostate Cancer (PC) and Metastatic Hormone-Sensitive Disease — Fred Saad, MD (4:18) Selection and Sequencing of Therapy for Patients with Metastatic CRPC (mCRPC) — A Oliver Sartor, MD (29:57) Integration of PARP Inhibitors into the Current Management of mCRPC — Himisha Beltran, MD (53:42) Available Data with, Ongoing Investigation of and Potential Future Role of PARP Inhibitor-Based Combinations — Alan H Bryce, MD (1:18:49) Novel Investigational Strategies for Patients with PC — Neeraj Agarwal, MD (1:44:48) CME information and select publications

Featuring perspectives from Prof Simon Chowdhury and Drs Tanya B Dorff and Matthew R Smith, including the following topics: Introduction (0:00) Choice of Androgen Deprivation Therapy (2:31) Nonmetastatic Castration-Resistant Prostate Cancer (13:01 Metastatic Hormone-Sensitive Prostate Cancer (41:11) CME information and select publications

A special audio program developed from a series of webinars held in conjunction with the 2021 ASCO Annual Meeting. Featuring perspectives from Drs Simon Chowdhury, Tanya B Dorff and Matthew R Smith.

Featuring slide presentations and related discussion from Prof Simon Chowdhury and Drs Tanya B Dorff and Matthew R Smith, including the following topics: Management of Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) — Matthew R Smith, MD, PhD (0:00) Therapeutic Options for Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), and Real-World Experiences — Simon Chowdhury, MD, PhD (32:00) Implications of Differential Toxicity for Treatment Selection in mHSPC and nmCRPC — Tanya B Dorff, MD (1:04:36) CME information and select publications

How do you know if hormonal therapy is right for you? On today's Health Minute, women's expert Dr. Kirtly Parker Jones explains why estrogen hormonal therapy is an effective way to treat symptoms of menopause, including hot flashes and dryness. Learn more about this health topic in the full-length interview.

Featuring an interview with Dr Roberto Iacovelli on the following topics: New hormonal therapies for prostate cancer (0:00) Risk of cardiovascular adverse events with new hormonal therapies for prostate cancer (2:45) Metabolic syndrome related to new hormonal therapies for prostate cancer (9:50) Bone fractures with androgen deprivation therapy (ADT) and new hormonal therapies for prostate cancer (13:30) Central nervous system toxicities and other adverse effects associated with new hormonal therapies for prostate cancer (17:14) Case: A man in his early 70s with metastatic castration-sensitive prostate cancer and a history of arterial hypertension (21:47) Case: A man in his early 60s with metastatic castration-sensitive prostate cancer and a history of rheumatoid arthritis, arterial hypertension and hepatitis C infection (26:55) Case: A man in his late 70s with nonmetastatic castration-resistant prostate cancer and a history of arterial hypertension (29:59) CME information and select publications

Featuring a discussion on hormonal therapies and the associated side effects in prostate cancer with Dr Roberto Iacovelli, moderated by Dr Neil Love.

Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayProstateHoromonalTherapy21).

Lara Briden is a naturopathic doctor and bestselling author of the book Period Repair Manual - a practical guide for treating period problems with nutrition, supplements, and bioidentical hormones. This year, Lara has released her new book, The Hormone Repair Manual, which explains how to navigate the change of perimenopause and relieve symptoms with natural treatments. In this episode, she explains the ins and outs of ‘second puberty’ and her favourite nutrients to support this time of life, as well as a fascinating evolutionary perspective on menopause. Tune in for a host of clinical gems! Highlights What motivated Lara to write The Hormone Repair Manual? (1:30) The perimenopausal years, aka ‘second puberty’ (4:00) Novel insights into nutrients for hormonal support (15:00) The recalibration process (19:00) Why you shouldn’t drink alcohol during perimenopause (25:30) Debunking the controversy surrounding phytoestrogens (29:00) The evolutionary take on menopause (33:00) Nutrients for perimenopause and menopause (43:00) Discussion regarding hormonal therapy (50:00) *Useful Links and Resources * https://www.larabriden.com/ https://www.larabriden.com/hormone-repair-manual/ Lara Briden on Instagram - https://www.instagram.com/larabriden/ Metagenics on Instagram - https://www.instagram.com/metagenics_anz/

Lara Briden is a naturopathic doctor and bestselling author of the book Period Repair Manual - a practical guide for treating period problems with nutrition, supplements, and bioidentical hormones. This year, Lara has released her new book, The Hormone Repair Manual, which explains how to navigate the change of perimenopause and relieve symptoms with natural treatments. In this episode, she explains the ins and outs of ‘second puberty’ and her favourite nutrients to support this time of life, as well as a fascinating evolutionary perspective on menopause. Tune in for a host of clinical gems! Highlights What motivated Lara to write The Hormone Repair Manual? (1:30) The perimenopausal years, aka ‘second puberty’ (4:00) Novel insights into nutrients for hormonal support (15:00) The recalibration process (19:00) Why you shouldn’t drink alcohol during perimenopause (25:30) Debunking the controversy surrounding phytoestrogens (29:00) The evolutionary take on menopause (33:00) Nutrients for perimenopause and menopause (43:00) Discussion regarding hormonal therapy (50:00) *Useful Links and Resources * https://www.larabriden.com/ https://www.larabriden.com/hormone-repair-manual/ Lara Briden on Instagram - https://www.instagram.com/larabriden/ Metagenics on Instagram - https://www.instagram.com/metagenics_anz/

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

Go online to PeerView.com/QAT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in urologic oncology discusses hormonal therapy in prostate cancer. Upon completion of this activity, participants should be better able to: Summarize the recent safety and efficacy data on novel hormonal therapy for metastatic castration-sensitive prostate cancer (mCSPC), as well as for other prostate cancer settings including castration-resistant (nmCRPC and mCRPC) disease, Counsel patients on current hormonal therapy standards for personalized management of prostate cancer, including for treatment selection based on disease progression, prior therapy, and patient characteristics, Design individualized, evidence-based treatment plans for patients with prostate cancer, taking into consideration disease, treatment, and patient-specific factors, Manage the spectrum of adverse events associated with novel hormonal therapies in patients with prostate cancer.

A special audio program developed from an oncology nursing educational webinar held in partnership with the ONS Bridge virtual conference. Featuring perspectives from Dr Andrew J Armstrong, Ms Molly Kim, Ms Ellen Leidig and Dr William K Oh.

Proceedings from an oncology nursing educational webinar held in partnership with the ONS Bridge virtual conference. Featuring perspectives from Dr Andrew J Armstrong, Ms Molly Kim, Ms Ellen Leidig and Dr William K Oh on the following topics: Introduction (0:00) Case: A man in his early 70s with metastatic hormone-sensitive prostate cancer (1:47) Case: A man in his mid-50s with metastatic castration-resistant prostate cancer (38:32) Case: A man in his late 70s with nonmetastatic prostate cancer (51:41) CME information and select publications

In this episode, Dr. Meredith Pittman (@merepitt) talks with Dr. Jan Heng of Beth Israel Deaconess Medical Center and Dr. Vanda Torous (@VandaTorousMD) of Massachusetts General Hospital about breast pathology and pathophysiology in the setting of gender-affirming hormonal therapy for our transgender patients. Featured public domain music: Loyalty Freak Music, I'M ON FIRE

In this episode of the Healthy and Strong podcast, Dr. Toni Harrison discusses a list of reasons for why menopause hormonal therapy is so important for people's health. Metagenics SPM Active To book an appointment, go to www.incrediblehealthcenter.com PhytoMulti with Iron is definitely one of my favorite multivitamins. Everyone should do a detox every 6 months due to all the chemicals in our world. ClearChange is a detox program that only takes 10 days. There is no restriction on how much you may eat, but there are restrictions on what types of things you may eat. For all of your vitamin and supplement needs, go to www.incrediblehealth.metagenics.com to order. Any purchase made through our affiliate link provides a commission to Incredible Health which helps us to be able to provide this podcast. We refuse to promote any product that we do not believe in. We appreciate your support.

In this episode we discuss the trial and error process of being on hormonal therapy.

http://www.drlizmd.com  Brains Dr. Elizabeth Lyster is an University of California at Irvine graduate, she also graduated from Cornell University with honors. Since 1990, Dr. Lyster has been helping patients with complex hormonal imbalances, metabolic conditions causing weight issues, thyroid dysfunction, and fatigue disorders. Through personal life experience, she has merged her medical training with alternative approaches to optimal health and well-being for men and women of all ages. Board certified in Obstetrics and Gynecology, she has special expertise in the treatment of perimenopause and menopause with bioidentical hormones. She is also the author of Easy Guide-Menopuse   https://www.amazon.com/Dr-Lizs-Easy-Guide-Menopause/dp/159932167X/ref=sr_1_1?ie=UTF8&qid=1498163892&sr=8-1&keywords=Easy+Guide+to+Menopause  

On this episode we visit the issue of Opioid (Pain Medication) Addiction. Addiction specialist, Dr. Tad Connine discusses the treatment options for this condition. We also discuss the benefits of Hormonal Therapy for Men and Women.

Each month the plastic surgery journal club reviews a recent paper The paper discussed here is Wang F, Peled AW, Chin R, Fowble B, Alvarado M, Ewing C, Esserman L, Foster R,Sbitany H. The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander-Implant Exchange in Prosthetic Breast Reconstruction. Plast Reconstr Surg. 2016 Jan;137(1):1-9.

The randomized placebo controlled trial of progesterone receptor blockade showed no difference in survival, finally answering the question about hormonal therapy in this disease and raising new questions about how to move forward quickly.

Hormone-sensitive breast cancer is the most common type of breast cancer. A hormone receptor test can be performed to help determine if cancer cells are sensitive to hormones, and if hormones in the body are helping cancer cells to grow. It can also be used to treat glands by blocking them from producing hormones—this may include removing a hormone-producing gland. The type of treatment used is based on many individual factors such as the size of the tumor and the patient’s age.Oncologist Dr. Merry Tetef discusses the causes, symptoms and treatments for hormone-sensitive breast cancers, including hormone blocking medication.

Host: Prathima Setty, MD Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients. Dr. Pinkerton is the Director for the Midlife Division and the Midlife Health Center, a nationally recognized multidisciplinary center for women's midlife health. She serves as a member of the Board of Trustees for the North American Menopause Society and the Board of Directors for the National Women's Health Resource Center. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive ...

Host: Prathima Setty, MD Post-menopausal patients have many options and choices for hormone therapy. But what are the issues and increased risks, if any? What are the latest updates from recent hormone therapy clinical trials and how does this impact clinical practice? Host Dr. Prathima Setty welcomes Dr. JoAnn V. Pinkerton to discuss various hormone therapy options and the latest updates in this area of concern for our patients. Dr. Pinkerton is the Director for the Midlife Division and the Midlife Health Center, a nationally recognized multidisciplinary center for women's midlife health. She serves as a member of the Board of Trustees for the North American Menopause Society and the Board of Directors for the National Women's Health Resource Center. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive ...

Dr. Samadi Tip Of The Week On Hormonal Therapy by Dr. Samadi

Tune into this 2hr show were we will be discussing the hot topic of insomnia with LIta Lee! www.litalee.com

Tune into this 2hr show were we will be discussing the hot topic of insomnia with LIta Lee! www.litalee.com

Paul E. Goss Massachusetts General Hospital Boston, MA

ProstateCancerUpdate.com/ThinkTank – Proceedings from a Clinical Investigator “Think Tank.” Controversial Issues in Hormonal Therapy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.